How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

XB

NASDAQ:XBIO
Get a brief AI stock analysisSaves ~ 15 minutes of your time

XB

Xenetic Biosciences IncNASDAQ XBIO Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is XBIO undervalued compared to its fair value?

The fair value of XBIO stock is hidden USD. Relative to the market price of 4.16 USD Xenetic Biosciences Inc is hidden.

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. The company is...[More about valuation]

Xenetic Biosciences Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.006 $B

Price:

4.16 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.776

FINANCIALS

Xenetic Biosciences financial for reporting period

Income Statement

0.0005 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0013 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0012 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.0005 B 100%
-0.0013 B -248%
-0.0012 B -234%

Balance Sheet

0.0094 B
0.0087 B

Financial Position Analysis

Assets

0.0094 B
Current Assets
0.0084 B
Total non-current assets
0.001 B

Total current liabilities
0.0007 B
Total non-current liabilities

Cash Flow Statement

-0.0012 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0012 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Xenetic Biosciences fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-43 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-453 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-40 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is XBIO attractive for investment based on fundamental analysis?

XBIO stock rating is hidden. Xenetic Biosciences is a hidden by Eyestock methodology.

Get XBIO Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-183

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

11.905

Debt / Equity ratio:

ROE:

-43

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

XBIO analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for XBIO to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Xenetic Biosciences Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Xenetic Biosciences Inc dividends

XBIO dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About XBIO stock

About the company Xenetic Biosciences Inc

Market cap $B

0.006

Dividend yield

Shares outstanding

15.1666 B

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. The company is headquartered in Framingham, Massachusetts and currently employs 4 full-time employees. The company went IPO on 2016-11-07. The firm is focused on developing XCART, a personalized Chimeric Antigen Receptor (CAR) T platform technology engineered to target patient- and tumor-specific neoantigens. The firm is advancing cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient’s malignant tumor cells, for the treatment of B-cell non-Hodgkin lymphomas. In addition, the Company is leveraging its drug delivery platform, PolyXen, by partnering with biotechnology and pharmaceutical companies. Its product pipeline includes XCART and ErepoXen, or polysialylated erythropoietin (PSA-EPO). PSA-EPO uses its PolyXen platform technology for the treatment of anemia in chronic kidney disease (CKD) patients. The company is designed to reduce the dosing frequency by extending the circulating half-life of therapeutic in the body.

XBIO profile

  • Ticker

    XBIO

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    07 November 2016

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    4

  • City

    Framingham

  • Address

    945 Concord St.

  • Cusip

    984015503